The Asian Development Bank (ADB) has invested US$75m in OrbiMed’s fourth healthcare fund, OrbiMed Asia Partners IV (OPA IV). The fund is focused on healthcare in India and China. OAP IV is expected to provide mainly growth capital to 15 to 20 health care companies across the biopharma, medical technology, healthcare services, diagnostics, and distribution…
©2023 All rights reserved LaingBuisson 
 has invested US$75m in OrbiMed’s fourth healthcare fund, OrbiMed Asia Partners IV){kind=link}